Is IND Swift Laboratories Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, IND Swift Laboratories Ltd (INDSWFTLAB.NS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is IND Swift Laboratories Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes IND Swift Laboratories Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of IND Swift Laboratories Ltd?

Muslim investors may consider investing in IND Swift Laboratories Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is IND Swift Laboratories Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of IND Swift Laboratories Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for IND Swift Laboratories Ltd updated?

The Shariah compliance status of IND Swift Laboratories Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like IND Swift Laboratories Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of IND Swift Laboratories Ltd?

You can check the latest Shariah compliance status of IND Swift Laboratories Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INDSWFTLAB.NS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 31, 2025

Report Source: 2026 2nd Quarter Report

IND Swift Laboratories Ltd. Stock Analysis INDSWFTLAB.NS

India Health Care Micro Cap Report: Q2, 2026

Ind-Swift Laboratories Ltd. engages in the manufacture, development, and market of pharmaceutical ingredients. The company is headquartered in Chandigarh, Chandigarh and currently employs 1,246 full-time employees. The company went IPO on 2002-03-15. The firm operates in the Pharmaceutical Business segment. The company also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.

Key Statistics of IND Swift Laboratories Ltd (INDSWFTLAB.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹132.90₹136.40

Today's Open

₹134.61

Volume

307.21K

P/E Ratio (TTM)

4.66

52 Week Range

₹70.71₹156.80

Market Cap

11.79B

Avg. Volume

1.47M

Dividend Yield

Financial Metrics & Statements of IND Swift Laboratories Ltd (INDSWFTLAB.NS)

FAQ's for IND Swift Laboratories Ltd (INDSWFTLAB.NS)

According to Musaffa’s Shariah screening methodology, IND Swift Laboratories Ltd (INDSWFTLAB.NS) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.